ATE472998T1 - Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis - Google Patents
Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritisInfo
- Publication number
- ATE472998T1 ATE472998T1 AT07725375T AT07725375T ATE472998T1 AT E472998 T1 ATE472998 T1 AT E472998T1 AT 07725375 T AT07725375 T AT 07725375T AT 07725375 T AT07725375 T AT 07725375T AT E472998 T1 ATE472998 T1 AT E472998T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- rheumatoid arthritis
- liposomal preparations
- cationic liposomal
- cationic
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 title abstract 2
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80107906P | 2006-05-18 | 2006-05-18 | |
| US87932007P | 2007-01-09 | 2007-01-09 | |
| PCT/EP2007/004467 WO2007134819A1 (en) | 2006-05-18 | 2007-05-18 | Cationic liposomal preparations for the treatment of rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE472998T1 true ATE472998T1 (de) | 2010-07-15 |
Family
ID=38512671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07725375T ATE472998T1 (de) | 2006-05-18 | 2007-05-18 | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090232731A1 (de) |
| EP (1) | EP2040674B1 (de) |
| AT (1) | ATE472998T1 (de) |
| DE (1) | DE602007007618D1 (de) |
| WO (1) | WO2007134819A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2086508A2 (de) * | 2006-11-03 | 2009-08-12 | MediGene Aktiengesellschaft | Kationische kolloidale träger zur abgabe von wirkstoffen an die blut-gehirn-schranke im verlauf von neuroinflammatorischen erkrankungen |
| US9770414B2 (en) * | 2010-05-13 | 2017-09-26 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent |
| CN103260702B (zh) | 2010-10-28 | 2018-07-27 | 帕西拉制药有限公司 | 非甾体类抗炎药的缓释制剂 |
| EP2638896A1 (de) * | 2012-03-14 | 2013-09-18 | Bioneer A/S | Kationisches liposomales Arzneimittelabgabesystem für spezifisches Targeting humaner CD14+ Monozyten in Vollblut |
| LT2854769T (lt) | 2012-07-05 | 2023-07-10 | Taiwan Liposome Company, Ltd. | Artrito gydymo būdai |
| KR102109188B1 (ko) | 2013-04-01 | 2020-05-11 | 삼성전자주식회사 | 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도 |
| WO2018094253A1 (en) | 2016-11-18 | 2018-05-24 | Pacira Pharmaceuticals, Inc. | Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same |
| EP3345614A1 (de) * | 2017-01-05 | 2018-07-11 | Amrif B.V. | Zusammensetzung mit alkalinphosphatase zur verwendung bei der behandlung von arthritiden |
| US11197820B2 (en) * | 2019-04-30 | 2021-12-14 | The Medical College Of Wisconsin, Inc. | Trans-tympanic membrane delivery platform and uses thereof |
| CN113616597A (zh) * | 2021-08-02 | 2021-11-09 | 上海交通大学 | 一种美洛昔康的注射剂及其制备方法和用途 |
| WO2025034892A2 (en) * | 2023-08-07 | 2025-02-13 | The University Of North Carolina At Chapel Hill | Ultrasound contrast agent for binding with or adhering to respiratory mucus and methods for using same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583153A (en) * | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
| AU751434B2 (en) * | 1997-12-23 | 2002-08-15 | Inex Pharmaceuticals Corporation | Polyamide oligomers |
| GB9808268D0 (en) * | 1998-04-17 | 1998-06-17 | Imp College Innovations Ltd | Compound |
| US6852334B1 (en) * | 1999-04-20 | 2005-02-08 | The University Of British Columbia | Cationic peg-lipids and methods of use |
| JP2004511426A (ja) * | 2000-05-03 | 2004-04-15 | ミュンヘン バイオテク アーゲー | 活性化血管部位に関連する陽イオン性の診断薬、画像化剤、および治療薬 |
| EP1374864A1 (de) * | 2002-06-26 | 2004-01-02 | Munich Biotech AG | Amphiphile, Taxane enthaltende Zusammensetzungen |
| CA2492080A1 (en) * | 2002-06-26 | 2004-01-08 | Medigene Oncology Gmbh | Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| EP2286794B8 (de) * | 2003-10-15 | 2016-06-01 | SynCore Biotechnology CO., LTD | Verwendung von kationischen liposomen mit paclitacel |
| US20050143336A1 (en) * | 2003-12-30 | 2005-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for improved non-viral gene therapy |
-
2007
- 2007-05-18 AT AT07725375T patent/ATE472998T1/de not_active IP Right Cessation
- 2007-05-18 EP EP07725375A patent/EP2040674B1/de not_active Not-in-force
- 2007-05-18 US US12/300,448 patent/US20090232731A1/en not_active Abandoned
- 2007-05-18 WO PCT/EP2007/004467 patent/WO2007134819A1/en not_active Ceased
- 2007-05-18 DE DE602007007618T patent/DE602007007618D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2040674A1 (de) | 2009-04-01 |
| US20090232731A1 (en) | 2009-09-17 |
| WO2007134819A1 (en) | 2007-11-29 |
| DE602007007618D1 (de) | 2010-08-19 |
| EP2040674B1 (de) | 2010-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE472998T1 (de) | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis | |
| EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
| EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
| EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| NO20076413L (no) | Multisykliske forbindelser og fremgangsmater for deres anvendelse | |
| EA201290209A1 (ru) | Новые модуляторы бензопиран киназы | |
| EA201071264A1 (ru) | Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера | |
| EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201170624A1 (ru) | Изоникотинамидные антагонисты рецепторов орексинов | |
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| EA201490922A1 (ru) | ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ | |
| EA200700035A1 (ru) | Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| EA201071245A1 (ru) | Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс | |
| EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
| EA201070822A1 (ru) | Доставка антител посредством модульного домена распознавания | |
| ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| ATE512948T1 (de) | Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
| MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
| MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |